By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Evogene today reported a 31 percent revenue spike for the third quarter ended Sept. 30.

The Rehovot, Israel-based plant genomics firm reported total revenues of $3.4 million for the quarter compared to $2.6 million for the third quarter of 2010.

Evogene's net loss for the quarter was $2.3 million, or $.07 per share, versus a loss of $3.6 million, or $.12 per share, for the third quarter of 2010.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

David Dobbs writes at Buzzfeed that genomics has delivered little on its promises.

In PNAS this week: co-evolutionary signatures of insect hosts and bacterial symbionts, distinct transcript isoforms of high-grade ovarian cancer, and more.

Adam Rutherford discusses genetic genealogy at the Guardian.

Portions of the US 21st Century Cures Act are raising some safety concerns.